MedTrace Logo

Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers

NCT02712619 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-03-18

No results posted yet for this study

Summary

Two doses of metformin with 12 hour interval

* low dose group (375/250 mg)
* high dose group (1000/1000mg)

Conditions

  • Healthy

Interventions

DRUG

Metformin

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-09-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02712619 on ClinicalTrials.gov